# Exposome Monitoring for Skin Diseases through Liquid Biopsy Multiomics

> **NIH NIH R21** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2024 · $105,449

## Abstract

Project Summary
Psoriasis and atopic dermatitis are common, immune-mediated skin diseases that are significantly influenced
by environmental factors. Developing remote monitoring technologies capable of capturing these
environmental factors and their effect on skin disease would advance exposome research. In this study, we
use non-invasive biosample collection methods and bioinformatic and machine learning approaches to monitor
changes in the skin of patients with psoriasis and atopic dermatitis. This study will advance our knowledge of
the cutaneous immunobiology of inflammatory skin disease and provide new paradigms for remote, home-
based research.

## Key facts

- **NIH application ID:** 11080629
- **Project number:** 3R21AR084041-01S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** Wilson Liao
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $105,449
- **Award type:** 3
- **Project period:** 2024-09-20 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11080629

## Citation

> US National Institutes of Health, RePORTER application 11080629, Exposome Monitoring for Skin Diseases through Liquid Biopsy Multiomics (3R21AR084041-01S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11080629. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*